glp-1 drugs and fatty liver glp 1 approved for nash Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-Associated Disease (MAFLD) A new study conducted by

This review has systematically summarized evidence suggesting that L-carnitine exerts multi-targeted actions against MASLD pathogenesis by promoting lipid metabolism, improving insulin sensitivity, stabilizing hepatocyte function, and inhibiting inflammatory and fibrotic signaling pathways

Boosts Energy and Endurance Enhances cellular energy production, helping to delay fatigue and improve training performance for active individuals

Nat Rev Neurosci 18(7):419434 Iadecola C (2013) The pathobiology of vascular dementia

Enter glutathione IV therapy, a potent therapy offering numerous benefits for physical and mental well-being